Civic Intelligence

Industry Pharmacogenomics Working Group C/O Contreras Legal Strategy LLC

990EZ • Fiscal year 2022 • EIN 83-0847467

Jan 01, 2022 to Dec 31, 2022 • Filed on Oct 30, 2023

Organization ProfileI-PWG.ORG
1711 Massachusetts Avenue 710Washington, DC 20038

(999) 999-9999

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

45th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2022 filings • 501(c)6 • <$500k nonprofits • Source year 2022

Liabilities / Revenue

45th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2022 filings • 501(c)6 • <$500k nonprofits • Source year 2022

Net Margin

9th percentile

-44%

Higher net margin than 9% of similar nonprofits.

2022 filings • 501(c)6 • <$500k nonprofits • Source year 2022

Top Officer Pay

72nd percentile

$0

Higher top officer pay than 72% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2022 filings • 501(c)6 • <$500k nonprofits • Source year 2022

Asset Growth

26th percentile

-13%

Faster asset growth than 26% of similar nonprofits.

2022 filings • 501(c)6 • <$500k nonprofits • Annualized from 2021 to 2022

Revenue Growth

10th percentile

-32%

Faster revenue growth than 10% of similar nonprofits.

2022 filings • 501(c)6 • <$500k nonprofits • Annualized from 2021 to 2022

Balance Sheet
Liabilities / Assets45th percentile

Assets

Down

$230,874

Down $35,037 (-13%) from 2021

Net Assets

Down

$230,874

Down $35,037 (-13%) from 2021

Liabilities

Flat

$0

Flat from 2021

Revenue And Expenses
Liabilities / Revenue45th percentileNet Margin9th percentile

Revenue

Down

$79,952

Down $37,033 (-32%) from 2021

Expenses

Up

$114,989

Up $28,946 (+34%) from 2021

Net Income

Down

-$35,037

Down $65,979 (-213%) from 2021

Historical Trend

Balance Sheet Trend

Asset Growth26th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$300K$200K$100K$0Assets 2018: $126,964Liabilities 2018: $02018Assets 2019: $169,373Liabilities 2019: $02019Assets 2020: $234,969Liabilities 2020: $0Net Assets 2020: $234,9692020Assets 2021: $265,911Liabilities 2021: $0Net Assets 2021: $265,9112021Assets 2022: $230,874Liabilities 2022: $0Net Assets 2022: $230,8742022Assets 2023: $262,032Liabilities 2023: $02023Assets 2024: $268,369Liabilities 2024: $0Net Assets 2024: $268,3692024

Highlighted filing

2022

Assets$230,874
Liabilities$0
Net Assets$230,874
Open 2022 Filing

Operations Trend

Revenue Growth10th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$150K$100K$50K$0-$50KRevenue 2018: $136,000Expenses 2018: $9,036Net Income 2018: $126,9642018Revenue 2019: $103,985Expenses 2019: $61,576Net Income 2019: $42,4092019Revenue 2020: $119,919Expenses 2020: $54,323Net Income 2020: $65,5962020Revenue 2021: $116,985Expenses 2021: $86,043Net Income 2021: $30,9422021Revenue 2022: $79,952Expenses 2022: $114,989Net Income 2022: -$35,0372022Revenue 2023: $120,092Expenses 2023: $88,934Net Income 2023: $31,1582023Revenue 2024: $109,962Expenses 2024: $103,625Net Income 2024: $6,3372024

Highlighted filing

2022

Revenue$79,952
Expenses$114,989
Net Income-$35,037
Open 2022 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2022 to Dec 31, 2022
Signed
Oct 30, 2023
Return Version
2022v5.0
Gross Receipts
$79,952
Mission and Program Overview

Mission

To improve patient care through integration of pharmacogenomics in drug development.

Program Services

DescriptionGrantsExpenses
THE ORGANIZATION PROVIDES INFORMATION AND SPONSORS EDUCATIONAL AND INFORMATIONAL PROGRAMS INTENDED TO PROMOTE A BETTER PUBLIC UNDERSTANDING OF PHARMACOGENOMIC RESEARCH. THE GROUP HAS MONTHLY TELECONFERENCES AND MEET FACE TO FACE ANNUALLY.$0$0
Compensation and Service Providers
Top Officer Pay72nd percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
CHARLES PAULDINGDirectorPT$0--
ADELE MITCHELLDirectorPT$0--
JULIAN ARBUCKLEDirectorPT$0--
Filing and Contact Details

Filer

Filer Name
Industry Pharmacogenomics Working Group
EIN
83-0847467
Address
1711 MASSACHUSETTS AVENUE 710, WASHINGTON, DC 20038

Signing Officer

Name
Julian Arbuckle
Title
Director
Signed
2023-10-30
Discuss with paid preparer
Yes

Preparer

Firm
Uhy Advisors Mo Inc
Address
15 SUNNEN DRIVE SUITE 100, ST LOUIS, MO 63143-3819
Preparer
Denise Pisciotta
Phone
3146151200
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 16 - Other Expenses

“Description: filing fees. Amount: 1,530. Description: bank fees. Amount: 431. Description: website maintenance. Amount: 9,250. Description: online subscription fees. Amount: 1,914. Description: consulting. Amount: 63,618. Description: vendor fees. Amount: 5,093. Description: miscellaneous. Amount: 22,145. Total to form 990-ez, line 16: 103,981.”

Raw XML Appendix106 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0JULIAN ARBUCKLE
IRS990EZ/BooksInCareOfDetail/PhoneNum09999999999
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt01711 MASSACHUSETTS AVE STE 710
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0WASHINGTON
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0DC
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd020038
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0265911
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0230874
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/ExcessOrDeficitForYearAmt0-35037
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt08260
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0265911
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0230874
IRS990EZ/GrossReceiptsAmt079952
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MembershipDuesAmt079952
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0265911
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0230874
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0265911
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0230874
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt05.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt15.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt210.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0CHARLES PAULDING
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1ADELE MITCHELL
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2JULIAN ARBUCKLE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2DIRECTOR
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501cInd0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherChangesInNetAssetsAmt00
IRS990EZ/OtherExpensesTotalAmt0103981
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0TO IMPROVE PATIENT CARE THROUGH INTEGRATION OF PHARMACOGENOMICS IN DRUG DEVELOPMENT.
IRS990EZ/PrintingPublicationsPostageAmt02748
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0THE ORGANIZATION PROVIDES INFORMATION AND SPONSORS EDUCATIONAL AND INFORMATIONAL PROGRAMS INTENDED TO PROMOTE A BETTER PUBLIC UNDERSTANDING OF PHARMACOGENOMIC RESEARCH. THE GROUP HAS MONTHLY TELECONFERENCES AND MEET FACE TO FACE ANNUALLY.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt00
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt00
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt00
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TotalExpensesAmt0114989
IRS990EZ/TotalRevenueAmt079952
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0I-PWG.ORG
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0DESCRIPTION: FILING FEES. AMOUNT: 1,530. DESCRIPTION: BANK FEES. AMOUNT: 431. DESCRIPTION: WEBSITE MAINTENANCE. AMOUNT: 9,250. DESCRIPTION: ONLINE SUBSCRIPTION FEES. AMOUNT: 1,914. DESCRIPTION: CONSULTING. AMOUNT: 63,618. DESCRIPTION: VENDOR FEES. AMOUNT: 5,093. DESCRIPTION: MISCELLANEOUS. AMOUNT: 22,145. TOTAL TO FORM 990-EZ, LINE 16: 103,981.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES
TransferPrsnlBnftContractsDecl/DeclarationDesc0THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/AuthenticationAssuranceLevelCd0AAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/IdentityAssuranceLevelCd0IAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/TrustedCustomerCd02
ReturnHeader/BuildTS02023-04-26 12:10:37Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0JULIAN ARBUCKLE
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0DIRECTOR
ReturnHeader/BusinessOfficerGrp/SignatureDt02023-10-30
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0INDUSTRY PHARMACOGENOMICS WORKING GROUP
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0C/O CONTRERAS LEGAL STRATEGY LLC
ReturnHeader/Filer/BusinessNameControlTxt0INDU
ReturnHeader/Filer/EIN0830847467
ReturnHeader/Filer/USAddress/AddressLine1Txt01711 MASSACHUSETTS AVENUE 710
ReturnHeader/Filer/USAddress/CityNm0WASHINGTON
ReturnHeader/Filer/USAddress/StateAbbreviationCd0DC
ReturnHeader/Filer/USAddress/ZIPCd020038
ReturnHeader/IRSResponsiblePrtyInfoCurrInd00
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0431305800
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0UHY ADVISORS MO INC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt015 SUNNEN DRIVE SUITE 100
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0ST LOUIS
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0MO
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0631433819
ReturnHeader/PreparerPersonGrp/PhoneNum03146151200
ReturnHeader/PreparerPersonGrp/PreparationDt02023-10-30
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0DENISE PISCIOTTA
ReturnHeader/ReturnTs02023-10-31T08:23:40-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0JULIAN
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0ARBUCKLE
ReturnHeader/TaxPeriodBeginDt02022-01-01
ReturnHeader/TaxPeriodEndDt02022-12-31
ReturnHeader/TaxYr02022

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2022 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$230,874
Liabilities
$0
Net assets
$230,874
Revenue
$79,952
Expenses
$114,989
Net income
-$35,037
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$2.68$0.00$2.68$1.10$1.04$0.06
2023Summary only. Only limited summary data is available for this year.$2.62$0.00$1.20$0.89$0.31
2022Detailed filing. Detailed filing data is available for this year.$2.31$0.00$2.31$0.80$1.15$0.35
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$2.66$0.00$2.66$1.17$0.86$0.31
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$2.35$0.00$2.35$1.20$0.54$0.66
2019Summary only. Only limited summary data is available for this year.$1.69$0.00$1.04$0.62$0.42
2018Summary only. Only limited summary data is available for this year.$1.27$0.00$1.36$0.09$1.27
Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 2022 filings • 501(c)6 • <$500k nonprofits